bioMerieux (OTCMKTS:BMXMF) Shares Cross Below Fifty Day Moving Average – Here’s Why

bioMerieux (OTCMKTS:BMXMF) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $92.82 and traded as low as $84.0750. bioMerieux shares last traded at $84.0750, with a volume of 6 shares traded.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on BMXMF. Deutsche Bank Aktiengesellschaft lowered shares of bioMerieux from a “buy” rating to a “hold” rating in a report on Friday, April 24th. Zacks Research upgraded shares of bioMerieux to a “hold” rating in a report on Tuesday, April 28th. Finally, UBS Group lowered shares of bioMerieux from a “buy” rating to a “neutral” rating in a report on Monday, June 1st. Four investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat, bioMerieux currently has an average rating of “Hold”.

bioMerieux Stock Down 0.2%

The company has a debt-to-equity ratio of 0.08, a current ratio of 2.39 and a quick ratio of 1.48. The stock’s 50-day simple moving average is $92.82 and its 200-day simple moving average is $110.81.

About bioMerieux

bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.